Clinical trials
Not yet recruiting Diabetes Mellitus trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2024 | 3 |
| 2025 | 7 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese PLA General Hospital | 2 |
| Sun Yat-sen University | 2 |
| First Affiliated Hospital of Wenzhou Medical University | 1 |
| Guangzhou University of Traditional Chinese Medicine | 1 |
| Haibo Shao | 1 |
| Hangzhou Reprogenix Bioscience, Inc | 1 |
| Hejiang Ye | 1 |
| Peking University First Hospital | 1 |
| Peking University Third Hospital | 1 |
| RenJi Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 20 |
| Diabetic Foot | 3 |
| Renal Insufficiency, Chronic | 3 |
| Cardiovascular Diseases | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Metabolic Syndrome | 2 |
| Carcinoma, Hepatocellular | 1 |
| Cognitive Dysfunction | 1 |
| Diabetic Retinopathy | 1 |
| Hyperlipidemias | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.